For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Immune Modulator

Livagen

Also known as: Lys-Glu-Asp-Ala

Livagen is a synthetic tetrapeptide (Lys-Glu-Asp-Ala / KEDA) from the Khavinson short-peptide 'bioregulator' series, developed at the St. Petersburg Institute of Bioregulation and Gerontology. Marketed in Russia primarily as a food-supplement-grade cytomax; not FDA-approved in the US; research-use only.

Where to buy · live market data

Who's worth your money for Livagen

Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.

Top Merit pick

Highest Merit Score (96) of 2 scored sellers

$4.00/mg

$79.97 · 20mg · 99.8% purity

5 COAs
Buy code MERIT · 15% off

Best value

Lowest $/mg among scored sellers

$2.10/mg

$420 · 200mg

no COAs yet

Average price

$3.82/mg

Sellers

10

45-day trend

+19.8%

8 of 10 sellers have a current price· 2 stale hidden· 4 unverified hidden

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Watch Livagen

Get one email when the market actually moves — no newsletter, no noise.

Compound reference

About Livagen

CAS

Molecular formula

C18H31N5O9

Sequence

KEDA

Typical dose range

100-500 mcg/day subcutaneous

Half-life

~30 minutes (estimated)

Independent evidence

COAs for Livagen

10 third-party tests across 3 vendors. Each card links to the full report.

All 10 COAs for Livagen →
Measured purity 99.0%–99.9% across 6 COAs
Measured purity over time
Research depth

12 citations indexed for Livagen

All research on Livagen →

review · 2025

Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties

Epitalon, also known as Epithalon or Epithalone, is a tetrapeptide, Ala-Glu-Asp-Gly (AEDG), which was synthesized based on the amino acids composition of Epithalamin, a bovine pineal gland extract, prior to its discovery in pineal gland polypeptide complex solution.

Study · 2023

EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON THE "OLD" CHROMATIN

In the present study, on the one hand, the epigenetic modification of condensed "old" chromatin was determined, and on the other hand, the influence of peptide bioregulators (Ala-Glu-Asp-Gly-Epitalon; Lys-Glu-Asp-Ala-Livagen; Ala-Glu-Asp-Pro - Cortagen and Lys-Glu - Vilon) on condensed chromatin in lymphocytes from old…

Study · 2020

[The influence of polypeptide liver complex and tetrapeptide KEDA on organism physiological function in norm and age-related pathology.]

The applying of many drugs in elderly and old people often is the reason of liver dysfunction. Thereat, the risk of liver fibroid induration, acute and chronic hepatitis increases during aging. It is the reason to find new, effective and harmless hepatoprotectors.

Study · 2017

[EVALUATION OF GENOMIC PARAMETERS IN DUCTAL BREAST CANCER PATIENTS AND THE ABILITY OF IT'S CORRECTION]

The level of DNA single strand breaks, chromosomal abnormalities and sister chromatid exchanges and the possibility of its normalization with oligopeptide bioregulator Livagen and cobalt ions in the lymphocyte culture from patients with breast cancer have been studied.

animal · 2017

Peptides (Epigenetic Regulators) in the Structure of Rodents with a Long and Short Lifespan

We have discovered motives of short-chain epigenetically active peptides in some proteins of long-lived African mole rat Heterocephalus glaber. These epigenetic regulators are located in the protein structure between lysine and arginine residues, thus facilitating their release in limited proteolysis.

Study · 2014

[Genomic instability in atherosclerosis]

A comparative study of the level of genomic instability, parameters of quantitative and structural mutations of chromosomes (aberration, aneuploidy, polyploidy) in lymphocyte cultures from patients with atherosclerosis of age 80 years and older (control group - 30-35 years old) was conducted.